GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (NSE:BIOFILCHEM) » Definitions » Capital Expenditure

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Capital Expenditure : ₹0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Biofil Chemicals & Pharmaceuticals's cash flow for capital expenditures for the three months ended in Jun. 2024 was ₹0.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was ₹0.00 Mil.

Biofil Chemicals & Pharmaceuticals Capital Expenditure Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Capital Expenditure Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.07 -5.67 -0.70 -0.11 -0.23

Biofil Chemicals & Pharmaceuticals Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biofil Chemicals & Pharmaceuticals Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (NSE:BIOFILCHEM) » Definitions » Capital Expenditure
Comparable Companies
BOM:524202 BOM:542934 BOM:524652 BOM:530233 BOM:524711 BOM:524636 BOM:506919 BOM:530317 BOM:539938 BOM:542248 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
524396:India
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Website
https://www.biofilgroup.net
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals Headlines

No Headlines